MX9804701A - METODO Y COMPOSICIONES PARA LA SINTESIS DE NUCLEOSIDAS DE DIOXOLANO CON CONFIGURACION beta. - Google Patents

METODO Y COMPOSICIONES PARA LA SINTESIS DE NUCLEOSIDAS DE DIOXOLANO CON CONFIGURACION beta.

Info

Publication number: MX9804701A
Authority: MX; Mexico
Prior art keywords: beta; compositions; synthesis; configuration; dioxolane nucleosides
Prior art date: 1995-12-14

Application number

MX9804701A

Other languages

English (en)

Spanish (es)

Inventor

Tarek Mansour

Alex Cimpoia

Krzysztof Bednarski

Original Assignee

Iaf Biochem Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-14

Filing date

1998-06-11

Publication date

1998-10-31

1998-06-11 Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int

1998-10-31 Publication of MX9804701A publication Critical patent/MX9804701A/es

Links

WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 title abstract 2
230000015572 biosynthetic process Effects 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
238000003786 synthesis reaction Methods 0.000 title abstract 2
239000002777 nucleoside Substances 0.000 title 1
230000001279 glycosylating effect Effects 0.000 abstract 1
229940127073 nucleoside analogue Drugs 0.000 abstract 1
230000000707 stereoselective effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MX9804701A 1995-12-14 1998-06-11 METODO Y COMPOSICIONES PARA LA SINTESIS DE NUCLEOSIDAS DE DIOXOLANO CON CONFIGURACION beta. MX9804701A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9525606.1A GB9525606D0 (en)	1995-12-14	1995-12-14	Method and compositions for the synthesis of dioxolane nucleosides with - configuration

Publications (1)

Publication Number	Publication Date
MX9804701A true MX9804701A (es)	1998-10-31

Family

ID=10785435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9804701A MX9804701A (es)	1995-12-14	1998-06-11	METODO Y COMPOSICIONES PARA LA SINTESIS DE NUCLEOSIDAS DE DIOXOLANO CON CONFIGURACION beta.

Country Status (27)

Country	Link
US (4)	US5922867A (2)
EP (1)	EP0970074B1 (2)
JP (1)	JP3229990B2 (2)
KR (1)	KR100406159B1 (2)
CN (1)	CN1080263C (2)
AP (1)	AP879A (2)
AT (1)	ATE214699T1 (2)
AU (1)	AU706328B2 (2)
BR (1)	BR9612351A (2)
CA (1)	CA2237730C (2)
DE (1)	DE69620042T2 (2)
DK (1)	DK0970074T3 (2)
EA (1)	EA000844B1 (2)
ES (1)	ES2172697T3 (2)
GB (1)	GB9525606D0 (2)
HU (1)	HU224076B1 (2)
IL (3)	IL144155A (2)
IN (1)	IN187349B (2)
MX (1)	MX9804701A (2)
NO (1)	NO309901B1 (2)
NZ (1)	NZ323855A (2)
OA (1)	OA11094A (2)
PL (1)	PL188447B1 (2)
PT (1)	PT970074E (2)
TW (1)	TW341574B (2)
WO (1)	WO1997021706A1 (2)
ZA (1)	ZA9610544B (2)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0986375A2 (en)	1997-04-07	2000-03-22	Triangle Pharmaceuticals Inc.	Use of mkc-442 in combination with other antiviral agents
ATE292631T1 (de) *	1998-08-12	2005-04-15	Gilead Sciences Inc	Verfahren zu herstellung von 1,3-oxathiolane nukleosiden
US6979561B1 (en) *	1998-10-09	2005-12-27	Gilead Sciences, Inc.	Non-homogeneous systems for the resolution of enantiomeric mixtures
MXPA01006425A (es)	1998-12-23	2002-06-04	Iaf Biochem Int	Analogos de nucleosido antivirales.
CA2362570A1 (en) *	1999-02-11	2000-08-17	Shire Biochem Inc.	Stereoselective synthesis of nucleoside analogues
CA2385349A1 (en) *	1999-09-24	2001-04-05	Francis J. Giles	Method for the treatment or prevention of viral infection using nucleoside analogues
US6566365B1 (en)	1999-11-04	2003-05-20	Biochem Pharma Inc.	Method for the treatment of Flaviviridea viral infection using nucleoside analogues
BR0104461A (pt) *	2000-02-10	2002-08-06	Mitsui Chemicals Inc	Processo seletivo para produzir um anÈmero a partir de um derivado de sacarìdeo 1-fosforilado e processo para produzir um nucleosìdeo
ATE360016T1 (de) *	2000-02-11	2007-05-15	Shire Biochem Inc	Ein stereoselektives verfahren zur herstellung von nukleosidanalogen
WO2002051852A1 (fr) *	2000-12-27	2002-07-04	Mitsui Chemicals, Inc.	Procede de production d'un derive de saccharide non naturel
CN102942563A (zh)	2001-03-01	2013-02-27	基利得科学公司	顺-ftc的多晶型物及其它晶型
AU2002329970A1 (en) *	2001-09-04	2003-03-18	Isis Pharmaceuticals, Inc.	Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase
US6645972B2 (en) *	2001-11-02	2003-11-11	Shire Biochem Inc.	Methods of treating leukemia
AU2002365234B2 (en) *	2001-12-14	2009-01-29	Pharmasset Inc	N4-acylcytosine nucleosides for treatment of viral infections
US20050085638A1 (en) *	2002-01-25	2005-04-21	Shire Biochem Inc	Process for producing dioxolane nucleoside analogues
AU2003294212B2 (en)	2002-08-06	2010-01-07	Pharmasset Inc.	Processes for preparing 1,3-dioxolane nucleosides
WO2004046214A2 (en)	2002-10-15	2004-06-03	Exxonmobil Chemical Patents Inc.	Multiple catalyst system for olefin polymerization and polymers produced therefrom
DE10335061B4 (de)	2003-07-31	2005-11-17	Wacker-Chemie Gmbh	Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
CA2554782C (en) *	2004-02-03	2013-08-13	Emory University	Methods to manufacture 1,3-dioxolane nucleosides
US7749531B2 (en) *	2005-06-08	2010-07-06	Indicator Systems International	Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) *	2007-07-30	2017-10-24	Rfs Pharma Llc	processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) *	2009-04-17	2012-01-25	中国石油化工股份有限公司	大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) *	2013-07-02	2013-09-11	山东大学	一种曲沙他滨的合成方法
WO2018022263A1 (en)	2016-07-29	2018-02-01	Exxonmobil Chemical Patents Inc.	Polymerization processes using high molecular weight polyhydric quenching agents
JP7337539B2 (ja)	2018-06-21	2023-09-04	メディヴィル・アクチエボラーグ	白血病療法のための塩基修飾シチジンヌクレオチド
WO2019245444A1 (en)	2018-06-21	2019-12-26	Medivir Ab	Base-modified cytidine nucleotides for leukemia therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5276151A (en) *	1990-02-01	1994-01-04	Emory University	Method of synthesis of 1,3-dioxolane nucleosides
CZ123493A3 (en) *	1992-06-22	1994-02-16	Lilly Co Eli	Stereoselective anionic glycosylation process

1995
- 1995-12-14 GB GBGB9525606.1A patent/GB9525606D0/en active Pending
1996
- 1996-12-13 PT PT96941539T patent/PT970074E/pt unknown
- 1996-12-13 IL IL14415596A patent/IL144155A/xx not_active IP Right Cessation
- 1996-12-13 WO PCT/CA1996/000845 patent/WO1997021706A1/en not_active Ceased
- 1996-12-13 ES ES96941539T patent/ES2172697T3/es not_active Expired - Lifetime
- 1996-12-13 TW TW085115392A patent/TW341574B/zh active
- 1996-12-13 NZ NZ323855A patent/NZ323855A/xx unknown
- 1996-12-13 DE DE69620042T patent/DE69620042T2/de not_active Expired - Lifetime
- 1996-12-13 CA CA002237730A patent/CA2237730C/en not_active Expired - Lifetime
- 1996-12-13 AP APAP/P/1998/001252A patent/AP879A/en active
- 1996-12-13 PL PL96327443A patent/PL188447B1/pl not_active IP Right Cessation
- 1996-12-13 EP EP96941539A patent/EP0970074B1/en not_active Expired - Lifetime
- 1996-12-13 KR KR10-1998-0704473A patent/KR100406159B1/ko not_active Expired - Fee Related
- 1996-12-13 AT AT96941539T patent/ATE214699T1/de not_active IP Right Cessation
- 1996-12-13 CN CN96199879A patent/CN1080263C/zh not_active Expired - Lifetime
- 1996-12-13 HU HU9901050A patent/HU224076B1/hu active IP Right Grant
- 1996-12-13 JP JP52157397A patent/JP3229990B2/ja not_active Expired - Lifetime
- 1996-12-13 DK DK96941539T patent/DK0970074T3/da active
- 1996-12-13 EA EA199800555A patent/EA000844B1/ru not_active IP Right Cessation
- 1996-12-13 BR BR9612351A patent/BR9612351A/pt not_active Application Discontinuation
- 1996-12-13 IN IN2810DE1996 patent/IN187349B/en unknown
- 1996-12-13 ZA ZA9610544A patent/ZA9610544B/xx unknown
- 1996-12-13 US US08/849,722 patent/US5922867A/en not_active Expired - Lifetime
- 1996-12-13 AU AU10893/97A patent/AU706328B2/en not_active Expired
- 1996-12-13 IL IL12466396A patent/IL124663A/en not_active IP Right Cessation
1998
- 1998-06-09 OA OA9800077A patent/OA11094A/en unknown
- 1998-06-11 MX MX9804701A patent/MX9804701A/es unknown
- 1998-06-12 NO NO982716A patent/NO309901B1/no unknown
1999
- 1999-02-17 US US09/251,431 patent/US6069250A/en not_active Expired - Lifetime
2001
- 2001-07-05 IL IL14415501A patent/IL144155A0/xx unknown
- 2001-11-16 US US09/987,845 patent/US20020058670A1/en not_active Abandoned
2002
- 2002-10-02 US US10/262,107 patent/US20030060476A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR100406159B1 (ko)	2004-11-16
NO309901B1 (no)	2001-04-17
IL144155A (en)	2003-07-06
EP0970074B1 (en)	2002-03-20
EA199800555A1 (ru)	1999-02-25
DE69620042D1 (de)	2002-04-25
WO1997021706A1 (en)	1997-06-19
EP0970074A1 (en)	2000-01-12
US20030060476A1 (en)	2003-03-27
JP2000501714A (ja)	2000-02-15
JP3229990B2 (ja)	2001-11-19
US5922867A (en)	1999-07-13
HK1017886A1 (en)	1999-12-03
US20020058670A1 (en)	2002-05-16
NO982716D0 (no)	1998-06-12
CA2237730A1 (en)	1997-06-19
AP879A (en)	2000-10-02
NO982716L (no)	1998-06-12
CN1080263C (zh)	2002-03-06
HUP9901050A3 (en)	2001-05-28
US6069250A (en)	2000-05-30
OA11094A (en)	2003-03-13
KR19990072141A (ko)	1999-09-27
DE69620042T2 (de)	2002-10-17
NZ323855A (en)	1999-11-29
IL124663A0 (en)	1998-12-06
AU706328B2 (en)	1999-06-17
AU1089397A (en)	1997-07-03
CA2237730C (en)	2001-12-04
BR9612351A (pt)	1999-07-13
GB9525606D0 (en)	1996-02-14
PL188447B1 (pl)	2005-02-28
ZA9610544B (en)	1997-07-29
CN1208414A (zh)	1999-02-17
ATE214699T1 (de)	2002-04-15
TW341574B (en)	1998-10-01
DK0970074T3 (da)	2002-07-15
IL124663A (en)	2001-10-31
HU224076B1 (hu)	2005-05-30
EA000844B1 (ru)	2000-06-26
IN187349B (2)	2002-03-30
ES2172697T3 (es)	2002-10-01
HUP9901050A2 (hu)	2001-04-28
PT970074E (pt)	2002-09-30
AP9801252A0 (en)	1998-06-30
IL144155A0 (en)	2002-05-23
PL327443A1 (en)	1998-12-07

Publication	Publication Date	Title
MX9804701A (es)	1998-10-31	METODO Y COMPOSICIONES PARA LA SINTESIS DE NUCLEOSIDAS DE DIOXOLANO CON CONFIGURACION beta.
DK0594291T3 (da)	2003-01-27	Fremgangsmåder til fremstilling af 13-etherderivater af milbemyciner og mellemprodukter dertil
DK0513200T3 (da)	1999-05-25	Fremgangsmåde og sammensætninger til syntese af BCH-189 og beslægtede forbindelser
ZA911153B (en)	1991-11-27	Process for the preparation of oxetanones
IL101932A0 (en)	1992-12-30	Processes for the diastereoselective synthesis of oxathiolane,dioxolane and dithiolane derivatives,and oxathiolane and dioxolane derivatives for use therein
DK0675893T3 (da)	1999-09-27	Antikonvulsive sorbopyranosesulfamater
IL87517A0 (en)	1989-01-31	Improvements in or relating to 2',2'-difluoronucleosides
NO974512L (no)	1997-09-29	Fremgangsmåte for syntese av nukleosid-analoger
CA2332974A1 (en)	1999-12-16	Morphine-6-glucuronide synthesis
IL131513A0 (en)	2001-01-28	Method for producing 1,3-di-substituted 2-nitroguanidines
HUP9702365A3 (en)	1999-09-28	Application of hydroxilamin-derivatives, as well as process and composition for increase of weather extreme resistent by cultivated plants
DK0640142T3 (da)	1998-10-07	Fremgangsmåde til fremtilling af avermectiner og kulturer hertil
ES8607929A1 (es)	1986-06-01	Un procedimiento para preparar un 10-ftalil-1, 5-diprotegido-1, 5, 10-triazadecano
HU9503816D0 (en)	1996-02-28	Process for producing of rodenticide composition with long storetime by tropical conditions